Zovirax: Effective Antiviral Treatment for Herpes Infections

Zovirax

Zovirax

Price from 52.00 $
Product dosage: 200mg
Package (num)Per pillPriceBuy
180$0.29$52.41 (0%)🛒 Add to cart
360
$0.26 Best per pill
$104.82 $93.74 (11%)🛒 Add to cart
Product dosage: 400mg
Package (num)Per pillPriceBuy
60$0.91$54.43 (0%)🛒 Add to cart
90$0.82$81.64 $73.58 (10%)🛒 Add to cart
120$0.77$108.86 $92.73 (15%)🛒 Add to cart
180$0.72$163.28 $130.02 (20%)🛒 Add to cart
270$0.69$244.93 $186.47 (24%)🛒 Add to cart
360
$0.68 Best per pill
$326.57 $243.92 (25%)🛒 Add to cart
Product dosage: 800mg
Package (num)Per pillPriceBuy
30$2.96$88.70 (0%)🛒 Add to cart
60$2.23$177.40 $134.05 (24%)🛒 Add to cart
90$1.99$266.09 $179.41 (33%)🛒 Add to cart
120$1.89$354.79 $226.78 (36%)🛒 Add to cart
180$1.76$532.19 $317.50 (40%)🛒 Add to cart
270$1.68$798.28 $454.58 (43%)🛒 Add to cart
360
$1.64 Best per pill
$1064.37 $591.65 (44%)🛒 Add to cart
Synonyms

Similar products

Zovirax (acyclovir) is a pioneering antiviral medication specifically formulated to manage and treat infections caused by the herpes simplex virus (HSV) and varicella-zoster virus (VZV). As a nucleoside analogue DNA polymerase inhibitor, it works by inhibiting viral replication, thereby reducing the severity and duration of outbreaks. Trusted by healthcare professionals globally, Zovirax is available in multiple formulations, including oral tablets, topical cream, and intravenous solutions, to provide targeted therapy based on clinical need and patient presentation.

Features

  • Active ingredient: Acyclovir
  • Available formulations: 200mg, 400mg, 800mg oral tablets; 5% topical cream; intravenous injection
  • Mechanism of action: Selective inhibition of viral DNA polymerase
  • Prescription status: Requires medical authorization
  • Manufacturer: GlaxoSmithKline (GSK)
  • FDA-approved since 1982

Benefits

  • Rapid reduction in viral shedding and lesion healing time
  • Decreased frequency and severity of recurrent herpes outbreaks
  • Effective prophylaxis in immunocompromised patients
  • Multiple administration routes for tailored treatment plans
  • Well-established safety profile with extensive clinical data
  • Minimizes risk of transmission to partners when used appropriately

Common use

Zovirax is indicated for the treatment of initial and recurrent episodes of genital herpes, herpes labialis (cold sores), herpes zoster (shingles), and chickenpox. It is also used prophylactically to prevent recurrence in immunocompetent and immunocompromised individuals, including patients with HIV or those undergoing chemotherapy. Off-label uses may include management of herpes simplex encephalitis and eczema herpeticum under specialist supervision.

Dosage and direction

Dosage varies significantly based on indication, patient immune status, and formulation:

  • Genital herpes (initial): 200mg orally every 4 hours while awake (5x daily) for 10 days
  • Genital herpes (recurrent): 200mg orally every 4 hours (5x daily) for 5 days
  • Chronic suppression: 400mg orally twice daily
  • Herpes zoster: 800mg orally every 4 hours (5x daily) for 7–10 days
  • Topical application: Apply to affected area every 3 hours (6x daily) for 7 days
  • IV administration: 5–10mg/kg every 8 hours for 7–10 days in hospitalized patients

Always complete the full prescribed course even if symptoms improve earlier. Dosage adjustments are necessary in renal impairment.

Precautions

  • Hydrate adequately to prevent crystalluria, especially with IV administration
  • Use with caution in elderly patients and those with renal impairment
  • Monitor renal function during prolonged therapy
  • Topical formulation is for external use only; avoid ocular contact
  • Not a cure for herpes infections; does not eliminate latent virus
  • May require dosage adjustment in patients receiving nephrotoxic drugs

Contraindications

  • Hypersensitivity to acyclovir, valacyclovir, or any component of the formulation
  • Severe renal impairment (CrCl <10 mL/min) without appropriate dosage adjustment
  • Concurrent administration with other nephrotoxic agents in high-risk patients
  • Topical formulation contraindicated on mucous membranes or immunocompromised patients with widespread lesions

Possible side effect

Common adverse reactions (≥1%):

  • Nausea (2.7%)
  • Headache (2.2%)
  • Diarrhea (1.7%)
  • Vomiting (1.5%)
  • Dizziness (1.3%)

Less frequent but serious effects:

  • Nephrotoxicity (crystalluria, elevated creatinine)
  • Neurotoxicity (tremors, confusion, hallucinations)
  • Hematological abnormalities (thrombocytopenia, leukopenia)
  • Hepatic enzyme elevations
  • Anaphylaxis (rare)
  • Topical: Local irritation, pruritus, rash

Drug interaction

  • Probenecid: Increases acyclovir plasma concentration by reducing renal clearance
  • Nephrotoxic agents (aminoglycosides, cyclosporine): Enhanced risk of renal impairment
  • Zidovudine: May cause increased drowsiness or lethargy
  • Mycophenolate mofetil: Potential additive effects on immunosuppression
  • Monitor closely when administered with other renally eliminated drugs

Missed dose

Take the missed dose as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. For topical formulation, apply at the next scheduled application time. Maintain regular dosing intervals to ensure consistent antiviral activity.

Overdose

Symptoms may include agitation, coma, seizures, and renal impairment. Management involves supportive care and hemodialysis (acyclovir is significantly dialyzable). Maintain adequate hydration and monitor renal function closely. Contact poison control center (1-800-222-1222) or emergency services immediately for guidance.

Storage

Store at room temperature (15–30°C/59–86°F) in original container. Protect from light and moisture. Keep all formulations out of reach of children. Do not freeze oral or topical formulations. IV solution should be used within 12 hours of reconstitution. Discard any unused medication properly according to local regulations.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment recommendations. Individual response to medication may vary. Proper diagnosis and supervision are essential for safe and effective use.

Reviews

“Zovirax has been transformative in my practice for managing herpes outbreaks. Patients report significantly reduced healing time and decreased pain with proper dosing.” – Dr. Elena Rodriguez, Infectious Disease Specialist

“After years of struggling with frequent recurrences, Zovirax suppression therapy has given me back control over my life. The side effects have been minimal compared to the benefit.” – Patient, 34

“Clinical trials demonstrate 75-85% reduction in recurrence rates with suppressive therapy. remains a cornerstone in antiviral management.” – Journal of Antimicrobial Chemotherapy, 2022